Phase 4
Completed N=188
Treatment for Post-Stroke Depression
Source: ClinicalTrials.gov NCT00029172 ↗Enrolled (actual)
188
Serious AEs
0.0%
Results posted
Jan 2010
Primary outcomePrimary: Twelve Week Depression Outcomes — 10.6 HAM-D depression score
Summary
The purpose of this study is to evaluate a program of education, medicine, and monitoring for the treatment of depression after a stroke.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Twelve Week Depression Outcomes |
10.6 | — |
Eligibility Criteria
- No severe language or cognitive deficits,
- life expectancy of at least 9 months, and
- willingness to participate.
Data sourced from ClinicalTrials.gov (NCT00029172). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.